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ABSTRACT 
Validation refers to establishing documented evidence that a process or system, when operated within established parameters, can perform 
effectively and reproducibly to produce a medicinal product meeting its pre-determined specifications and quality attributes. Validation of the 
individualsteps of the processes is called the process validation. Process validation involves the collection and evaluation of data, from the process 
design stage throughout production, that establish scientific evidence that a process is capable of consistently delivering a quality drug substance. It 
is internationally recognized that validation is necessary in analyticallaboratories. The use of validated methods is important for an 
analyticallaboratory to show its qualification and competency.This new approach to process validation encompasses equipmentand utility 
qualification and is fully science and risk-based. Itprovides the pharmaceutical industry with the opportunity tore-think the whole concept of 
validation and ensure that theseactivities add real value to our businesses and to patients.It involves prospective validation, retrospective validation 
and concurrent validation.A life-cycle approach should be applied linking product and process development, validation of the commercial 
manufacturing process and maintenance of the process in a state of control during routine commercial production 
Keywords: Validation, prospective validation, concurrent validation, retrospective  validation, quality by design.
INTRODUCTION 
Validation, as it is known today, has developed from the need to 
maintain quality,consistency, and above all, public safety. Validation 
is a rapidly growing and evolvingsubject. This evolution stems from 
technology’s astonishing growth rate, especially interms of what is 
available in computer hardware and software.[1,2] 
Over the past 15 years,machine automation and process control 
through the use of a computer has causedadditional concerns 
relating the validation of the processing system. Today, the 
computeris used for everything from controlling the process, to 
automatically provide batchreports, and providing automated 
quality control.The foundation of validation, the methodology 
behind validation, and the need forvalidation will likely remain a key 
aspect of the industry we work in.[2,3]. This session reflectsthe 
current industry trends and serves as an educational tool in our 
progressive industry. 
Process validation establishes the flexibility andconstraints in the 
manufacturing process controls in theattainment of desirable 
attributes in the drug productwhile preventing undesirable 
properties.[3] This is animportant concept, since it serves to support 
theunderlying definition of validation, which is a 
systematicapproach to identifying, measuring, evaluating, 
documenting, and re-evaluating a series of critical steps inthe 
manufacturing process that require control to ensurea reproducible 
final product.[4] 
USFDA defined process validation as “establishingdocumented 
evidence which provides a high degree ofassurance that a specific 
process will consistently producea product meeting its 
predetermined specifications andquality characteristics.”[1] 
The basic principles for validation may be stated as follows: 
 Establish that the process equipment has the capability of 
operating within required parameters; 
 Demonstrate that controlling, monitoring, and/or 
measuring equipment and instrumentation are capable of 
operating within the parameters prescribed for the 
process equipment; [5] 
 Perform replicate cycles (runs) representing the required 
operational range of the equipment to demonstrate that  
 
 the processes have been operating within the prescribed 
parameters for the process and that the output or product 
consistently meets predetermined specifications for 
quality and function; and 
 Monitor the validated process during routine operation. 
As needed, requalify and recertify the equipment.[4,6] 
 
Fig. 1: Flow chart describing validation process [1] 
Validation in itself does not improve processes but confirms that the 
processes have been properly developed and are under control. 
Adequate validations have been proved beneficial to manufacturer 
in many ways: 
 It deepens the understanding of process 
 decreases the risk of defect cost 
 decreases risk of regulatory non compliance 
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TYPES OF PROCESS VALIDATION 
1. Prospective Process Validation. Where anexperimental plan called 
the validation protocol isexecuted (following completion of the 
qualification trials) before the process is put to commercial use. 
Mostvalidation efforts require some degree of 
prospectiveexperimentation in order to generate validation 
supportdata.[10] 
2. Concurrent Process Validation. Establishingdocumented evidence 
that the process is in a state ofcontrol during the actual 
implementation of the process.This is normally performed by 
conducting in-processtesting and/or monitoring of critical 
operations during themanufacture of each production 
batch.Concurrent validation is feasible when nondestructive testing 
is adequate to verify that products meet predetermined 
specifications and quality attributes. [8,9] 
3. Retrospective Process Validation. Where historic datataken from 
the records of the completed productionbatches are used to provide 
documented evidence thatthe process has been in a state of control 
prior to therequest for such evidence.[5]. This type of validation 
makes use of historical data and information which may be found in 
batch records, production log books, lot records, control charts, test 
and inspection results, customer complaints or lack of complaints, 
field failure reports, service reports, and audit reports.[10] 
4. Revalidation: Revalidation means repeating the original validation 
effort or any part of it, and includes an investigative review of 
existing performance data. This approach is essential to maintain the 
validated status of the plant, equipment, manufacturing processes 
and computer systems. [11]. Possible reasons for starting the 
revalidation process include: 
• The transfer of a product from one plant to another. 
• Changes to the product, the plant, the manufacturing 
process, the cleaning process, or other changes that 
could affect product quality. 
• The necessity of periodic checking of the validation 
results. [10] 
• Significant (usually an order of magnitude) increase 
or decrease in batch size. 
• Sequential batches that fail to meet product and 
process specifications. 
• The scope of revalidation procedures depends on the 
extent of the changes and the effect upon the 
product.[3] 
 
THE REGULATORY BASIS FOR PROCESS VALIDATION  
The concept of process validation from its beginnings inthe early 
1970s through the regulatory aspects associated with current good 
manufacturing practice (cGMP) regulations and the application 
thereof to various analytical, quality assurance, pilot plant, 
production, andsterile product and solid dosage forms 
considerations. There are several important reasons for validating a 
product and/or process [12] 
First, manufacturers are required by law to conform tocGMP 
regulations. Second, good business dictates that a manufacturer 
avoids the possibility of rejected or recalled batches. Third, 
validation helps to ensure product uniformity, reproducibility, and 
quality. [13] 
 
Fig. 2: Validation life cycle [1] 
THE STAGES OF PROCESS VALIDATION 
1. Process Design: Definition of the process based on knowledge 
gained throughout development and scale-up activities. Process 
design involves two important phases: 
• Building and capturing process knowledge and 
understanding 
• Establishing a strategy for process control, which 
may or may not incorporate PAT principles.[14,4] 
The process design stage delivers the planned commercial 
production and control records, which contain the operational limits 
and overall strategy for process control. 
2. Process Qualification:It states that “Each manufacturer should 
judge whether it has gained sufficient understanding to provide a 
high degree of assurance in its manufacturing process to justify 
commercial distribution of the product.”[15] 
3. Continued Process Verification:Ongoing assurance, gained during 
routine production thatthe process remains in a state of control. 
Having confirmed that the process design is capable of reproducible 
commercial manufacture, the manufacturer must continually assure 
that the process remains in a state of control throughout commercial 
manufacture. [16] 
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Fig. 3: Stages of Process Validation [7] 
MANUFACTURING PROCESS VALIDATION 
 
Fig. 4:Manufacturing Process Validation Workflow [4] 
 
(1) Installation Qualification: Establishing by objective 
evidence that all key aspects of the process equipment and ancillary 
system installation adhere to the approved design criteria and that 
the recommendations of the manufacturer of the equipment are 
suitably considered. [14] 
(2) Operational Qualification: Establishing by objective 
evidence parameters which result in production that meets all 
predetermination requirements. [14] 
(3) Performance Qualification: Establishing by objective 
evidence that the process, under anticipated conditions, including 
worst case conditions, consistently produces a product which meets 






QUALITY BY DESIGN: AN ALTERNATIVE APPROACH TO PROCESS 
VALIDATION  
A systematic approach to development that begins with predefined 
objectives and emphasizes product and process understanding and 
process control, based on sound science and quality risk 
management. [17] 
Quality by Design (QbD)–“Means that product and process 
performance characteristics are scientifically designed to meet 
specific objectives, not merely empirically derived from 
performance of test batches.”[20] 
Traditional approach in process validation focuses on three 
validation lots at commercial scale. Process validation is considered 
complete when the results of these lots are within acceptance 
criteria as defined in the validation protocol. [18, 20] 
 
 
Fig. 5:Quality by Design Model [21] 
An alternative approach to traditional process validation is the 
continuous process verification, which adopts the concept of Quality 
by Design (QbD). It emphasizes on a life cycle approach where the 
process is continued to be verified even after the validation lots.[19] 
QbD is related to about having a Control Strategy, about Knowing 
and Controlling Variation, having Quality Built In and Continuing 
Validation beyond the three batches.[20] 
BENEFITS OF APPLICATION OF QBD APPROACH TO 
ANALYTICAL METHODS 
• Development of a robust method 
• Applicable throughout the life cycle of the product 
[22] 
• Regulatory flexibility 
• Movements within “Design Space” are not 
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CHARACTERISTICS OF A SUCCESSFUL QBD PROGRAM 
1. Involves product design and process development 
2. Risk-based, science based 
3. Primary focus is patient safety and product efficacy 
4. Business benefits are also drivers [23] 
5. Results in improved process understanding 
6. Results in improved process capability/robustness 
7. Systematic development[24] 
8. Holistic – applies to all aspects of development 
9. Multivariate – interactions are modeled 
10. Provides PAR, design space, or suitable equivalent 
11. Requires a significant reduction in regulatory 
oversight post approval[25, 26] 
REFERENCES 
1. “Guideline on General Principles of Process 
Validation” (US Food and Drug Administration, 5600 
Fishers Lane, Rockville, Maryland 20857, USA, 
1987). 
2. “Annex 15 to the EU Guide to Good Manufacturing 
Practice — Qualification and Validation” (European 
Commission, Rue de la Loi, Wetstraat 200, B-1049 
Brussels, Belgium, 2001). 
3. Aulton M. E., pharmaceutics, the science ofdosage 
form design, international edition,second edition, 
Churchill Livingston (Elsevier),2006, 1. 
4. Robert A Nash, Alfred H Wachter,Pharmaceutical 
Process Validation, Third Edition,volume 129, 
Marcel Dekker, Inc, New York, 2003,159-180 
5. ICH-Q2A, Guideline for Industry: Text on Validation 
of AnalyticalProcedures, 1995 
(http://www.fda.gov/cder/guidance/index.htm). 
6. Isabel Taverniers, Marc De Loose, Erik Van 
Bockstaele, Trends in quality in the 
analyticallaboratory. II. Analytical methodvalidation 

























7. ICH guideline Q11 on development and manufacture 
of drug substances (chemical entities and 
biotechnological/biological entities),  May 
2011EMA/CHMP/ICH/425213/2011 ICH/ 
Committee for medicinal products for human use 
(CHMP), pg no- 13 
8. Peter Gough “Modern approaches to process 
validation”, journal of NSF-DBA, issue 20, US winter 
2012,The Health Sciences,Training, Consultancyand 
Auditing Experts, pg no. 1-4. Journal of NS 
9. South African guide to Good Manufacturing Practice, 
Medicine Control Council, Pretoria, 1996. 
10. Guideline on General Principles of Process 
Validation, May 1987, FDA, CDRH/CDER 
11. Journal of Validation Technology, Vol. 1, No. 4, 
August 1995 
12. FDA Guide on APIs, March 1998, page 48; PICGuide, 
March 1999, page 32; Gold Sheet, Feb1999, 6. 
13. Chaitanya kumar G, Rout RP, Ramtake 
S,Bhattachaiya S, Process Validation, The 
Indianpharmacist, Aug 2005, 14-19. 
14. Kathiresan K, Kiran K, Basics of Validation-
Pharmaceutical Perspective, first edition, 
K.K.Publishers, Chidambaram, 2005, 32-46. 
15. A History of Validation in the United States A paper 
presented by Kenneth Chapman at the ISPE Annual 
Meeting, 1994 - Kemper-Masterson, Inc. 
16. Computer Systems Validation for the Pharmaceutical 
and Medical Device Industries, Richard Chamberlain, 
Alaren Press 1991 
17. Guideline on General Principles of Process Validation 
- Center for Drugs and Biologics and Center for 
Devices and Radiological Health, Food and Drug 
Administration, May 1987. 
18. Code of Federal Regulations, CFR 21 - Part 210 and 
211 - Food and Drug Administration - April 1990 
Revision 
Aspect Current state Desired QbD state 
Pharmaceutical development 





Locked down; validation on 
three batches; focus on reproducibility 
Adjustable within design space; 
continuous verification within 
design space; focus on control 
strategy 
Process control 
In-process testing for 
go/no-go; offline analysis 
PAT utilized for feedback and 
feed forward in real time 
Product specification 
Primary means of quality 
control; based on batch data 
Part of an overall quality control 
strategy; based on product 
performance 
Control strategy 
Mainly by intermediate and 
end product testing 




Reactive to problems and 
OOS; post approval changes 
Needed 
Continual improvement enabled 
within design space 
Varshney et al. 




19. GAMP 3 – Good Automated Manufacturing Practices 
version 3.0, ISPE 
20. Yubing Tang, Ph.D.”Quality by Design Approaches to 
Analytical Methods” –FDA/CDER/ONDQA AAPS, 
Washington DC, October 25, 2011, 1-21. 
21. Guidance for Industry, Process Validation: General 
Principles and Practices, U.S. Department of Health 
and Human Services Food and Drug Administration, 
CDER, CBER, CVM, Current Good Manufacturing 
Practices (CGMP), Revision 1, January 2001 
22. Chatterjee, Wong and Rafa, Using Operational 
Excellence to Meet the New Process Validation 
Guidance, Pharmaceutical Engineering, Sept 2011. 
23. Immel, B.G. (2005) A brief history ofGMPs. Regul. 
Compliance Newslett.,winter. 
24. U.S. Department of Health and HumanServices Food 
and Drug Administration(2004) Pharmaceutical 
cGMPS for the21st Century – A Risk-Based 
Approach:Second Progress Report and 
ImplementationPlan. 
25. U.S. Department of Health and HumanServices Food 
and Drug Administration(2007) Pharmaceutical 
Quality for the 21stCentury: A Risk-Based Approach. 
http://www.fda.gov/oc/cgmp/report0507.html. 
26. Juran, J.M. (1992) Juran on Quality byDesign – The 
New Steps for PlanningQuality into Goods and 
Services, the FreePress. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
